State-dependent responses to intracranial brain stimulation in a patient with depression
- PMID: 33462446
- PMCID: PMC8284979
- DOI: 10.1038/s41591-020-01175-8
State-dependent responses to intracranial brain stimulation in a patient with depression
Erratum in
-
Publisher Correction: State-dependent responses to intracranial brain stimulation in a patient with depression.Nat Med. 2022 Oct;28(10):2218. doi: 10.1038/s41591-022-01950-9. Nat Med. 2022. PMID: 35941379 No abstract available.
Abstract
Deep brain stimulation is a promising treatment for severe depression, but lack of efficacy in randomized trials raises questions regarding anatomical targeting. We implanted multi-site intracranial electrodes in a severely depressed patient and systematically assessed the acute response to focal electrical neuromodulation. We found an elaborate repertoire of distinctive emotional responses that were rapid in onset, reproducible, and context and state dependent. Results provide proof of concept for personalized, circuit-specific medicine in psychiatry.
Conflict of interest statement
Competing interests
A.D.K. consults for Eisai, Evecxia, Ferring, Galderma, Harmony Biosciences, Idorsia, Jazz, Janssen, Merck, Neurocrine, Pernix, Sage, Takeda, Big Health, Millenium Pharmaceuticals, Otsuka Pharmaceuticals, and Neurawell. All other authors declare no competing interests.
Figures


Comment in
-
The future of personalized brain stimulation.Nat Med. 2021 Feb;27(2):196-197. doi: 10.1038/s41591-021-01243-7. Nat Med. 2021. PMID: 33526929 No abstract available.
References
-
- Disease GBD, Injury I & Prevalence C Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet 392, 1789–1858 (2018). - PMC - PubMed
-
- Howland RH Sequenced treatment alternatives to relieve depression (STAR*D). Part 2: study outcomes. J. Psychosoc. Nurs. Ment. Health Serv. 46, 21–24 (2008). - PubMed
-
- Mayberg HS et al. Deep brain stimulation for treatment-resistant depression. Neuron 45, 651–660 (2005). - PubMed
-
- Holtzheimer PE et al. Subcallosal cingulate deep brain stimulation for treatment-resistant depression: a multisite, randomised, sham-controlled trial. Lancet Psychiatry 4, 839–849 (2017). - PubMed
-
- Dougherty DD et al. A randomized sham-controlled trial of deep brain stimulation of the ventral capsule/ventral striatum for chronic treatment-resistant depression. Biol. Psychiatry 78, 240–248 (2015). - PubMed
Publication types
MeSH terms
Grants and funding
- R01 AG060477/AG/NIA NIH HHS/United States
- R01 MH111444/MH/NIMH NIH HHS/United States
- UH3 NS115631/NS/NINDS NIH HHS/United States
- UH3 NS109556/NS/NINDS NIH HHS/United States
- R01 AG059794/AG/NIA NIH HHS/United States
- K23 NS110962/NS/NINDS NIH HHS/United States
- R01 DC015504/DC/NIDCD NIH HHS/United States
- K23NS110962/U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
- U24 DA041123/DA/NIDA NIH HHS/United States
- R01 DC012377/DC/NIDCD NIH HHS/United States
- R01 NS105675/NS/NINDS NIH HHS/United States
- U01 NS098971/NS/NINDS NIH HHS/United States
- P01 AG019724/AG/NIA NIH HHS/United States
- R01 DK117953/DK/NIDDK NIH HHS/United States
- R01 MH114860/MH/NIMH NIH HHS/United States
- R01 HL142051/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical